Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel pyroptosis-related gene signature in human spermatogenic dysfunction. | J Assist Reprod Genet | 2023 | 37553495 | PubTator, text mining | PubMed |
| Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker. | Brain Tumor Res Treat | 2023 | 37550819 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma. | Transl Oncol | 2023 | 37549605 | PubTator, text mining | PubMed |
| Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy. | Mol Ther Nucleic Acids | 2023 | 37547288 | PubTator, text mining | PubMed |
| Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients. | Medicine (Baltimore) | 2023 | 37543772 | PubTator, text mining | PubMed |
| Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells. | Cell Commun Signal | 2023 | 37542283 | PubTator, text mining | PubMed |
| The role of NLRP3 in regulating gingival epithelial cell responses evoked by Aggregatibacter actinomycetemcomitans. | Cytokine | 2023 | 37541072 | PubTator, text mining | PubMed |
| Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation. | Mol Med Rep | 2023 | 37539739 | PubTator, text mining | PubMed |
| Application of multiple machine learning approaches to determine key pyroptosis molecules in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37538791 | PubTator, text mining | PubMed |
| Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. | J Immunother Cancer | 2023 | 37536941 | PubTator, text mining | PubMed |
| Role and significance of SIRT1 in regulating the LPS-activated pyroptosis pathway in children with congenital hydronephrosis. | World J Pediatr Surg | 2023 | 37534327 | PubTator, text mining | PubMed |
| PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. | Front Oncol | 2023 | 37519797 | PubTator, text mining | PubMed |
| New insights into regulatory cell death and acute pancreatitis. | Heliyon | 2023 | 37519748 | PubTator, text mining | PubMed |
| The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment. | Molecules | 2023 | 37513375 | PubTator, text mining | PubMed |
| Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma. | Cancers (Basel) | 2023 | 37509327 | PubTator, text mining | PubMed |
| Cognitive Impairment in Multiple Sclerosis. | Bioengineering (Basel) | 2023 | 37508898 | PubTator, text mining | PubMed |
| Disruption of the Mammalian Ccr4-Not Complex Contributes to Transcription-Mediated Genome Instability. | Cells | 2023 | 37508532 | PubTator, text mining | PubMed |
| NRF2 transcriptionally regulates Caspase-11 expression to activate HMGB1 release by Autophagy-deficient hepatocytes. | Cell Death Discov | 2023 | 37507374 | PubTator, text mining | PubMed |
| Entire Expressed Peripheral Blood Transcriptome in Pediatric Severe Malarial Anemia. | Res Sq | 2023 | 37503086 | PubTator, text mining | PubMed |
| The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas. | Front Mol Neurosci | 2023 | 37501725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=17